Back to search

Article

Ruscogenin Alleviates Intestinal Bleeding and Blood Flow Induced by Dasatinib through ROCK/MLC Pathway

2020-10-26

Abstract excerpt

<title>Abstract</title> <p>BackgroundAs a second-generation broad-spectrum tyrosine kinase inhibitor, Dasatinib has the antitumor effect of inhibiting tyrosine kinases such as BCR-ABL and SRC. It is mainly used to treat chronic and acute patients with chronic myelogenous leukemia. However, Dasatinib has many side effects, including gastrointestinal bleeding, respiratory infections, and renal failure, and effectiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cd974eab-1c91-590c-99c3-184356c271f4
DOI
10.21203/rs.3.rs-96134/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ruscogenin Alleviates Intestinal Bleeding and Blood Flow Induced by Dasatinib&nbsp;through ROCK/MLC PathwayDOI 10.21203/rs.3.rs-96134/v1
Select a neighboring publication to make it the new centre.